RecruitingPhase 2NCT03908736

Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation

Thinking Zinc: A Study of Zinc Supplementation to Ameliorate Adverse Effects of Mine Waste Exposure on the Navajo Nation

Sponsor

University of New Mexico

Enrollment

100 participants

Start Date

May 19, 2019

Study Type

INTERVENTIONAL

Conditions

Immune System Disorder DNA Damage

Summary

This is a study to assess the effect of dietary zinc supplementation to mitigate biomarkers of metal toxicity in exposed tribal populations.

Eligibility

Min Age: 21 YearsMax Age: 64 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Zinc Picolinate 15 Mg for people with dna damage and immune system disorder. The study is currently recruiting participants at 1 location. People eligible for this study include aged 21 Years to 64 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.